ImmunityBio Shares Jump 10% on Erdogan Meeting
ImmunityBio (IBRX) closed up 9.94% at $9.29 after Dr. Patrick Soon-Shiong met President Erdogan, fueling hopes for the company's planned cancer-treatment expansion into Turkey.
Topic
Topic
ImmunityBio (IBRX) closed up 9.94% at $9.29 after Dr. Patrick Soon-Shiong met President Erdogan, fueling hopes for the company's planned cancer-treatment expansion into Turkey.
Viking Therapeutics closed up 35.67% at $40.85 after VK2735 trial patients lost 16-19% of body weight. The real draw: less freque…
Butterfly Network surged 21.99% to $9.93 after Needham launched coverage with a Buy rating and $10 target, while hedge fund holdi…
Snowflake shares have jumped 185% from April lows as product revenue growth accelerated to 37%, but a 166.7x forward multiple and…
Jim Cramer says Cintas enters its September 23 earnings report with a full head of steam, but a 36x forward P/E and UniFirst deal…
Gabelli's Small Cap Growth Fund returned 14.44% in Q2 2026, trailing the Russell 2000's 21.49%. Holding Gorman-Rupp trades near $…
Hedge funds backed a record number of billion-dollar VC funding rounds, per Institutional Investor, as crossover capital reshapes…
Minot Light returned 26.2% gross in Q2 2026 and named Sonida Senior Living (SNDA) a top idea, citing a multi-year upcycle in priv…
The London Company cut its Matson (NYSE:MATX) position after a 122.95% one-year gain, citing the need to reduce weight while prai…
CCC Intelligent Solutions has fallen 30.48% over 52 weeks on AI disruption fears, but The London Company argues its insurance pla…
Minot Light returned 20.3% net in Q2 2026 and named Rockwell Medical a below-net-cash buy it expects to be sustainably cash flow…